Wall Street investors weighing the impacts of Donald Trump’s trade war on Corporate America sent stocks climbing amid bets ...

The volatility across all markets these past two weeks rivals what we endured in the 2008 Great Financial Crisis and the 2020 ...

China’s economy expanded by a better-than-expected 5.4% in the first quarter even as U.S. tariff threats mount.

China is set to post its first-quarter GDP data. Reuters’ economists expect a 5.1% growth year-on-year, compared to a 5.4% in ...

Others offered a more optimistic spin. Craig Johnson, chief market technician at Piper Sandler, said his research shows that ...

Investors digested President Donald Trump’s latest tariff exemptions and looked toward a big week for first-quarter earnings.

3. A top strategist is waiting for a stock surge. Piper Sandler's Craig Johnson isn't backing down from his high price target for the S&P 500, even despite current volatility. Here's why he still ...

In a report released today, Edward Tenthoff from Piper Sandler maintained a Buy rating on CytomX Therapeutics (CTMX – Research Report), with a price target of $2.50. The company’s shares ...

Piper Sandler analyst David Westenberg reiterated a Hold rating on Neogen (NEOG – Research Report) today and set a price target of $6.40. The company’s shares closed last Friday at $5.58.

Piper Sandler analyst David Westenberg maintained a Hold rating on Akoya Biosciences (AKYA – Research Report) today and set a price target of $1.65. The company’s shares closed last Friday at ...

Piper Sandler analyst David Westenberg maintained a Hold rating on Pacific Biosciences (PACB – Research Report) today and set a price target of $2.00. The company’s shares closed last Friday ...

In a report released today, Ryan Todd from Piper Sandler maintained a Buy rating on Conocophillips (COP – Research Report), with a price target of $114.00. The company’s shares closed last ...